Published in Vision Res on June 16, 2011
A method to estimate the amount of neuroretinal rim tissue in glaucoma: comparison with current methods for measuring rim area. Am J Ophthalmol (2013) 1.19
Improved estimates of visual field progression using bayesian linear regression to integrate structural information in patients with ocular hypertension. Invest Ophthalmol Vis Sci (2012) 1.01
Evaluation of the Structure-Function Relationship in Glaucoma Using a Novel Method for Estimating the Number of Retinal Ganglion Cells in the Human Retina. Invest Ophthalmol Vis Sci (2015) 0.85
Assessing assumptions of a combined structure-function index. Ophthalmic Physiol Opt (2015) 0.76
Correlating perimetric indices with three nerve fiber layer thickness measures. Optom Vis Sci (2013) 0.75
Using perimetric data to estimate ganglion cell loss for detecting progression of glaucoma: a comparison of models. Ophthalmic Physiol Opt (2017) 0.75
The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol (2002) 11.38
Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol (2003) 8.76
A framework for comparing structural and functional measures of glaucomatous damage. Prog Retin Eye Res (2007) 4.64
Long-term intraocular pressure fluctuation and progressive visual field deterioration in patients with glaucoma and low intraocular pressures after a triple procedure. Arch Ophthalmol (2007) 3.78
Variation of nerve fibre layer thickness measurements with age and ethnicity by scanning laser polarimetry. Br J Ophthalmol (1997) 3.55
A visual field index for calculation of glaucoma rate of progression. Am J Ophthalmol (2008) 3.46
Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology (2004) 3.14
Early detection of visual field progression in glaucoma: a comparison of PROGRESSOR and STATPAC 2. Br J Ophthalmol (1997) 2.88
Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol (2001) 2.84
A new generation of algorithms for computerized threshold perimetry, SITA. Acta Ophthalmol Scand (1997) 2.68
Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Ophthalmology (2006) 2.66
Linking structure and function in glaucoma. Prog Retin Eye Res (2010) 2.43
Structure versus function in glaucoma: an application of a linear model. Invest Ophthalmol Vis Sci (2007) 2.36
Scaling the hill of vision: the physiological relationship between light sensitivity and ganglion cell numbers. Invest Ophthalmol Vis Sci (2000) 2.33
Structure-function relationships using confocal scanning laser ophthalmoscopy, optical coherence tomography, and scanning laser polarimetry. Invest Ophthalmol Vis Sci (2006) 2.17
Delaying treatment of ocular hypertension: the ocular hypertension treatment study. Arch Ophthalmol (2010) 2.14
Visual field defects and neural losses from experimental glaucoma. Prog Retin Eye Res (2002) 2.05
Neural losses correlated with visual losses in clinical perimetry. Invest Ophthalmol Vis Sci (2004) 2.04
A test of a linear model of glaucomatous structure-function loss reveals sources of variability in retinal nerve fiber and visual field measurements. Invest Ophthalmol Vis Sci (2009) 1.96
Visual field defects and retinal ganglion cell losses in patients with glaucoma. Arch Ophthalmol (2006) 1.83
The relationship between nerve fiber layer and perimetry measurements. Invest Ophthalmol Vis Sci (2007) 1.83
Analysis of visual field progression in glaucoma. Br J Ophthalmol (1996) 1.78
Response variability in the visual field: comparison of optic neuritis, glaucoma, ocular hypertension, and normal eyes. Invest Ophthalmol Vis Sci (2000) 1.75
Evaluation of the structure-function relationship in glaucoma. Invest Ophthalmol Vis Sci (2005) 1.64
An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma. Am J Ophthalmol (2004) 1.50
Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data. Invest Ophthalmol Vis Sci (2008) 1.47
Examination of different pointwise linear regression methods for determining visual field progression. Invest Ophthalmol Vis Sci (2002) 1.46
Diffuse loss of sensitivity in early glaucoma. Invest Ophthalmol Vis Sci (1999) 1.44
Relating retinal nerve fiber thickness to behavioral sensitivity in patients with glaucoma: application of a linear model. J Opt Soc Am A Opt Image Sci Vis (2007) 1.31
Visual field progression in glaucoma: total versus pattern deviation analyses. Invest Ophthalmol Vis Sci (2005) 1.29
False-negative responses in glaucoma perimetry: indicators of patient performance or test reliability? Invest Ophthalmol Vis Sci (2000) 1.29
Psychophysical investigation of ganglion cell loss in early glaucoma. J Glaucoma (2005) 1.29
A new pattern electroretinogram paradigm evaluated in terms of user friendliness and agreement with perimetry. Ophthalmology (2007) 1.28
Comparing multifocal VEP and standard automated perimetry in high-risk ocular hypertension and early glaucoma. Invest Ophthalmol Vis Sci (2007) 1.24
Properties of the statpac visual field index. Invest Ophthalmol Vis Sci (2011) 1.23
Development and evaluation of a contrast sensitivity perimetry test for patients with glaucoma. Invest Ophthalmol Vis Sci (2008) 1.19
Longitudinal and cross-sectional analyses of visual field progression in participants of the Ocular Hypertension Treatment Study. Arch Ophthalmol (2010) 1.18
The psychophysics of glaucoma: improving the structure/function relationship. Prog Retin Eye Res (2005) 1.16
Structure and function in glaucoma: The relationship between a functional visual field map and an anatomic retinal map. Invest Ophthalmol Vis Sci (2006) 1.15
Perimetric indices as predictors of future glaucomatous functional change. Optom Vis Sci (2011) 1.04
Correlation of visual function with optic nerve and nerve fiber layer structure in glaucoma. Surv Ophthalmol (1989) 1.03
Structure-function relationship depends on glaucoma severity. Br J Ophthalmol (2009) 0.99
Sensitivity loss in early glaucoma can be mapped to an enlargement of the area of complete spatial summation. Invest Ophthalmol Vis Sci (2010) 0.97
Ganglion cell loss and dysfunction: relationship to perimetric sensitivity. Optom Vis Sci (2008) 0.90
Development and evaluation of a linear staircase strategy for the measurement of perimetric sensitivity. Vision Res (2006) 0.89
The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol (2002) 16.89
The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol (2002) 11.38
A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol. Am J Ophthalmol (2003) 9.99
Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A. Arch Ophthalmol (2010) 2.78
Delaying treatment of ocular hypertension: the ocular hypertension treatment study. Arch Ophthalmol (2010) 2.14
Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses. Arch Ophthalmol (2004) 1.80
Classification of visual field abnormalities in the ocular hypertension treatment study. Arch Ophthalmol (2003) 1.76
Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment. Arch Ophthalmol (2004) 1.71
Evaluation of the structure-function relationship in glaucoma. Invest Ophthalmol Vis Sci (2005) 1.64
Quantitation of cardiolipin molecular species in spontaneously hypertensive heart failure rats using electrospray ionization mass spectrometry. J Lipid Res (2005) 1.61
An examination of physiological mechanisms underlying the frequency-doubling illusion. Invest Ophthalmol Vis Sci (2002) 1.57
Pulsar perimetry in the diagnosis of early glaucoma. Am J Ophthalmol (2009) 1.57
The Nature of Macular Damage in Glaucoma as Revealed by Averaging Optical Coherence Tomography Data. Transl Vis Sci Technol (2012) 1.55
'Structure-function relationship' in glaucoma: past thinking and current concepts. Clin Experiment Ophthalmol (2012) 1.53
Normative ranges and specificity of the multifocal VEP. Doc Ophthalmol (2004) 1.52
Comparison of different methods for detecting glaucomatous visual field progression. Invest Ophthalmol Vis Sci (2003) 1.46
Frequency-doubling technology perimetry. Ophthalmol Clin North Am (2003) 1.34
Identification of progressive glaucomatous visual field loss. Surv Ophthalmol (2002) 1.33
Properties of perimetric threshold estimates from full threshold, ZEST, and SITA-like strategies, as determined by computer simulation. Invest Ophthalmol Vis Sci (2003) 1.30
How useful is population data for informing visual field progression rate estimation? Invest Ophthalmol Vis Sci (2013) 1.29
Psychophysical investigation of ganglion cell loss in early glaucoma. J Glaucoma (2005) 1.29
A new pattern electroretinogram paradigm evaluated in terms of user friendliness and agreement with perimetry. Ophthalmology (2007) 1.28
Development of efficient threshold strategies for frequency doubling technology perimetry using computer simulation. Invest Ophthalmol Vis Sci (2002) 1.27
Selective loss of an oscillatory component from temporal retinal multifocal ERG responses in glaucoma. Invest Ophthalmol Vis Sci (2002) 1.26
Linearity can account for the similarity among conventional, frequency-doubling, and gabor-based perimetric tests in the glaucomatous macula. Optom Vis Sci (2006) 1.26
Comparing multifocal VEP and standard automated perimetry in high-risk ocular hypertension and early glaucoma. Invest Ophthalmol Vis Sci (2007) 1.24
Determining abnormal latencies of multifocal visual evoked potentials: a monocular analysis. Doc Ophthalmol (2004) 1.23
Using machine learning classifiers to identify glaucomatous change earlier in standard visual fields. Invest Ophthalmol Vis Sci (2002) 1.23
Staging functional damage in glaucoma: review of different classification methods. Surv Ophthalmol (2007) 1.20
Characteristics of the normative database for the Humphrey matrix perimeter. Invest Ophthalmol Vis Sci (2005) 1.19
Flavin-dependent antioxidant properties of a new series of meso-N,N'-dialkyl-imidazolium substituted manganese(III) porphyrins. Biochem Pharmacol (2004) 1.19
Development and evaluation of a contrast sensitivity perimetry test for patients with glaucoma. Invest Ophthalmol Vis Sci (2008) 1.19
Community visual field screening: prevalence of follow-up and factors associated with follow-up of participants with abnormal frequency doubling perimetry technology results. Ophthalmic Epidemiol (2007) 1.18
Longitudinal and cross-sectional analyses of visual field progression in participants of the Ocular Hypertension Treatment Study. Arch Ophthalmol (2010) 1.18
The association between glaucomatous visual fields and optic nerve head features in the Ocular Hypertension Treatment Study. Ophthalmology (2006) 1.16
Comparison of the new perimetric GATE strategy with conventional full-threshold and SITA standard strategies. Invest Ophthalmol Vis Sci (2008) 1.16
Performance of efficient test procedures for frequency-doubling technology perimetry in normal and glaucomatous eyes. Invest Ophthalmol Vis Sci (2002) 1.14
Effect of dichoptic adaptation on frequency-doubling perimetry. Optom Vis Sci (2002) 1.14
Evaluation of a two-stage neural model of glaucomatous defect: an approach to reduce test-retest variability. Optom Vis Sci (2006) 1.12
Comparison of glaucomatous visual field defects using standard full threshold and Swedish interactive threshold algorithms. Arch Ophthalmol (2002) 1.12
Frequency-doubling technology perimetry and optical defocus. Invest Ophthalmol Vis Sci (2003) 1.11
Progression of visual field loss in untreated glaucoma patients and glaucoma suspects in St. Lucia, West Indies. Am J Ophthalmol (2002) 1.10
The Heidelberg retina tomograph Glaucoma Probability Score: reproducibility and measurement of progression. Ophthalmology (2010) 1.10
The methodology of visual field testing with frequency doubling technology in the National Health and Nutrition Examination Survey, 2005-2006. Ophthalmic Epidemiol (2010) 1.09
Size threshold perimetry performs as well as conventional automated perimetry with stimulus sizes III, V, and VI for glaucomatous loss. Invest Ophthalmol Vis Sci (2013) 1.09
Anterior lamina cribrosa surface depth, age, and visual field sensitivity in the Portland Progression Project. Invest Ophthalmol Vis Sci (2014) 1.08
The repeatability of mean defect with size III and size V standard automated perimetry. Invest Ophthalmol Vis Sci (2013) 1.06
Determining abnormal interocular latencies of multifocal visual evoked potentials. Doc Ophthalmol (2004) 1.05
Glaucomatous progression in series of stereoscopic photographs and Heidelberg retina tomograph images. Arch Ophthalmol (2010) 1.04
Comparing the effectiveness of telemedicine and traditional surveillance in providing diabetic retinopathy screening examinations: a randomized controlled trial. Telemed J E Health (2013) 1.04
Factors predicting the rate of functional progression in early and suspected glaucoma. Invest Ophthalmol Vis Sci (2012) 1.04
Perimetric indices as predictors of future glaucomatous functional change. Optom Vis Sci (2011) 1.04
Mechanisms isolated by frequency-doubling technology perimetry. Invest Ophthalmol Vis Sci (2002) 1.03
Causes of visual impairment and common eye problems in Northwest American Indians and Alaska Natives. Am J Public Health (2005) 1.03
Effect of treatment on the rate of visual field change in the ocular hypertension treatment study observation group. Invest Ophthalmol Vis Sci (2012) 1.03
Assessment of patient opinions of different clinical tests used in the management of glaucoma. Ophthalmology (2008) 1.03
Variability of visual field measurements is correlated with the gradient of visual sensitivity. Vision Res (2007) 1.02
Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years. Arch Ophthalmol (2010) 1.01
Decline of photopic multifocal electroretinogram responses with age is due primarily to preretinal optical factors. J Opt Soc Am A Opt Image Sci Vis (2002) 1.01
Within-test variability of frequency-doubling perimetry using a 24-2 test pattern. J Glaucoma (2002) 1.01
IOP-induced lamina cribrosa deformation and scleral canal expansion: independent or related? Invest Ophthalmol Vis Sci (2011) 1.00
Sensitivity and specificity of the Swedish interactive threshold algorithm for glaucomatous visual field defects. Ophthalmology (2002) 1.00
Nonlinear, multilevel mixed-effects approach for modeling longitudinal standard automated perimetry data in glaucoma. Invest Ophthalmol Vis Sci (2013) 1.00
Blur-resistant perimetric stimuli. Optom Vis Sci (2013) 0.99
Estimation of spatial scale across the visual field using sinusoidal stimuli. Invest Ophthalmol Vis Sci (2012) 0.99
A cortical pooling model of spatial summation for perimetric stimuli. J Vis (2006) 0.98
Is there evidence for continued learning over multiple years in perimetry? Optom Vis Sci (2008) 0.98
Visual field quality control in the Ocular Hypertension Treatment Study (OHTS). J Glaucoma (2007) 0.97
Assessment of contrast gain signature in inferred magnocellular and parvocellular pathways in patients with glaucoma. Vision Res (2008) 0.96
Rapid pupil-based assessment of glaucomatous damage. Optom Vis Sci (2008) 0.96
Use of a continuous probability scale to display visual field damage. Arch Ophthalmol (2009) 0.95
Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study. Arch Ophthalmol (2005) 0.95
Variability of rarebit and standard perimetry sizes I and III in normals. Optom Vis Sci (2011) 0.94
Repeatability of normal multifocal VEP: implications for detecting progression. J Glaucoma (2006) 0.93
Asymmetries and visual field summaries as predictors of glaucoma in the ocular hypertension treatment study. Invest Ophthalmol Vis Sci (2006) 0.93
Normal age-related sensitivity loss for a variety of visual functions throughout the visual field. Optom Vis Sci (2006) 0.93
Predictive value of frequency doubling technology perimetry for detecting glaucoma in a developing country. J Glaucoma (2005) 0.92
Imaging and Perimetry Society standards and guidelines. Optom Vis Sci (2011) 0.92
Series length used during trend analysis affects sensitivity to changes in progression rate in the ocular hypertension treatment study. Invest Ophthalmol Vis Sci (2013) 0.91
The effect of test variability on the structure-function relationship in early glaucoma. Graefes Arch Clin Exp Ophthalmol (2012) 0.91
Predicting progressive glaucomatous optic neuropathy using baseline standard automated perimetry data. Invest Ophthalmol Vis Sci (2008) 0.89
Development and evaluation of a linear staircase strategy for the measurement of perimetric sensitivity. Vision Res (2006) 0.89
Structure and function in patients with glaucomatous defects near fixation. Optom Vis Sci (2011) 0.88
Sensitivity differences between real-patient and computer-stimulated visual fields. J Glaucoma (2002) 0.88
Estimating quality-adjusted life year losses associated with visual field deficits using methodological approaches. Ophthalmic Epidemiol (2007) 0.88
The visualFields package: a tool for analysis and visualization of visual fields. J Vis (2013) 0.88
Elevated vernier acuity thresholds in glaucoma. Invest Ophthalmol Vis Sci (2002) 0.88
Assessment of false positives with the Humphrey Field Analyzer II perimeter with the SITA Algorithm. Invest Ophthalmol Vis Sci (2006) 0.87
Sensitivity and specificity of the Humphrey Matrix to detect homonymous hemianopias. Invest Ophthalmol Vis Sci (2008) 0.87
Scotoma mapping by semi-automated kinetic perimetry: the effects of stimulus properties and the speed of subjects' responses. Acta Ophthalmol Scand (2006) 0.87
Pupillary evaluation of retinal asymmetry: development and initial testing of a technique. Vision Res (2005) 0.86